Research Scientist of Pharmacoepidemiology.
Hemorrhagic stroke associated with antidepressant use in patients with depression: does degree of serotonin reuptake inhibition matter?
Article first published online: 30 DEC 2008
Copyright © 2009 John Wiley & Sons, Ltd.
Pharmacoepidemiology and Drug Safety
Volume 18, Issue 3, pages 196–202, March 2009
How to Cite
Chen, Y., Guo, J. J. and Patel, N. C. (2009), Hemorrhagic stroke associated with antidepressant use in patients with depression: does degree of serotonin reuptake inhibition matter?. Pharmacoepidem. Drug Safe., 18: 196–202. doi: 10.1002/pds.1699
- Issue published online: 20 FEB 2009
- Article first published online: 30 DEC 2008
- Manuscript Accepted: 13 NOV 2008
- Manuscript Revised: 5 NOV 2008
- Manuscript Received: 14 APR 2008
This article has been cited by:
- 1Models of Care for Late-Life Depression of the Medically Ill: Examples from Chronic Obstructive Pulmonary Disease and Stroke, The American Journal of Geriatric Psychiatry, 2015, 23, 5, 477, ,
- 2Safety of selective serotonin reuptake inhibitor treatment in recovering stroke patients, Expert Opinion on Drug Safety, 2015, 14, 6, 911, ,
- You have free access to this content4
- 6Tradeoffs between accuracy measures for electronic health care data algorithms, Journal of Clinical Epidemiology, 2012, 65, 3, 343, , ,
- 7Effects of Selective Serotonin Reuptake Inhibitors on Platelet Function, Drugs & Aging, 2011, 28, 5, 345,
- 9Hospital Pharmacy Pulse - Recent Publications on Medications and Pharmacy, Hospital Pharmacy, 2009, 44, 5, 439,